The Latin America, Middle East and Africa Digital Health For Cardiovascular Market is expected to witness market growth of 23.9% CAGR during the forecast period (2024-2031).
The Brazil market dominated the LAMEA Digital Health For Cardiovascular Market by country in 2023, and is expected to continue to be a dominant market till 2031; thereby, achieving a market value of $3.13 billion by 2031. The Argentina market is showcasing a CAGR of 24.7% during 2024-2031. Additionally, the UAE market would register a CAGR of 22.6% during 2024-2031.
On a global scale, organizations like the World Health Organization (WHO) have advocated for the adoption of digital health strategies to combat non-communicable diseases, including cardiovascular disease. WHO’s Global Digital Health Strategy 2020-2025 emphasizes the role of digital tools in improving cardiovascular disease management and supporting health systems in leveraging data, remote monitoring, and telemedicine.
Moreover, there has been a noticeable shift in healthcare approaches worldwide in recent years, with an increasing emphasis on preventive healthcare, particularly in cardiology. A major driver of this shift is public education and awareness campaigns led by governments and non-governmental organizations (NGOs).
Cardiovascular diseases (CVD) remain one of the most critical health challenges in the LAMEA region, significantly contributing to mortality rates and healthcare system burdens. In Brazil, for instance, CVD is the leading cause of death, with approximately one-third of all deaths attributed to cardiovascular conditions, according to AHA journals. Noncommunicable diseases (NCDs), which include CVD, account for 72% of all deaths in the country. In 2019, nearly 400,000 people died from CVDs in Brazil, with myocardial infarction (23.9%), stroke (14.1%), and heart failure (8.9%) being the primary causes. Moreover, heart failure was the leading reason for hospital admissions, accounting for over 222,000 admissions in 2019 alone. Over the past 30 years, Brazil has seen a 26.8% increase in the prevalence of CVD, with 5,454 age-standardized CVD cases per 100,000 men and 475 cases per 100,000 women in 2019. These statistics highlight the growing need for digital cardiovascular solutions to improve disease management and reduce hospitalization rates. As the LAMEA region undergoes significant demographic, technological, and healthcare transformations, the adoption of digital cardiovascular solutions, telecardiology, and remote monitoring systems is expected to rise.
The Brazil market dominated the LAMEA Digital Health For Cardiovascular Market by country in 2023, and is expected to continue to be a dominant market till 2031; thereby, achieving a market value of $3.13 billion by 2031. The Argentina market is showcasing a CAGR of 24.7% during 2024-2031. Additionally, the UAE market would register a CAGR of 22.6% during 2024-2031.
On a global scale, organizations like the World Health Organization (WHO) have advocated for the adoption of digital health strategies to combat non-communicable diseases, including cardiovascular disease. WHO’s Global Digital Health Strategy 2020-2025 emphasizes the role of digital tools in improving cardiovascular disease management and supporting health systems in leveraging data, remote monitoring, and telemedicine.
Moreover, there has been a noticeable shift in healthcare approaches worldwide in recent years, with an increasing emphasis on preventive healthcare, particularly in cardiology. A major driver of this shift is public education and awareness campaigns led by governments and non-governmental organizations (NGOs).
Cardiovascular diseases (CVD) remain one of the most critical health challenges in the LAMEA region, significantly contributing to mortality rates and healthcare system burdens. In Brazil, for instance, CVD is the leading cause of death, with approximately one-third of all deaths attributed to cardiovascular conditions, according to AHA journals. Noncommunicable diseases (NCDs), which include CVD, account for 72% of all deaths in the country. In 2019, nearly 400,000 people died from CVDs in Brazil, with myocardial infarction (23.9%), stroke (14.1%), and heart failure (8.9%) being the primary causes. Moreover, heart failure was the leading reason for hospital admissions, accounting for over 222,000 admissions in 2019 alone. Over the past 30 years, Brazil has seen a 26.8% increase in the prevalence of CVD, with 5,454 age-standardized CVD cases per 100,000 men and 475 cases per 100,000 women in 2019. These statistics highlight the growing need for digital cardiovascular solutions to improve disease management and reduce hospitalization rates. As the LAMEA region undergoes significant demographic, technological, and healthcare transformations, the adoption of digital cardiovascular solutions, telecardiology, and remote monitoring systems is expected to rise.
List of Key Companies Profiled
- Apple, Inc.
- Orange S.A.
- Epic Systems Corporation
- Siemens Healthineers AG (Siemens AG)
- GE HealthCare Technologies, Inc.
- CardiAI.Inc
- Vista.ai (HeartVista, Inc.)
- Viz.ai, Inc.
- Cleerly, Inc.
- RSIP Vision Ltd.
Market Report Segmentation
By Component
- Services
- Software
- Hardware
By End-use
- Patients
- Providers
- Payers
- Other End-use
By Country
- Brazil
- Argentina
- UAE
- Saudi Arabia
- South Africa
- Nigeria
- Rest of LAMEA
Table of Contents
Chapter 1. Market Scope & Methodology
Chapter 2. Market at a Glance
Chapter 3. Market Overview
Chapter 4. Competition Analysis - Global
Chapter 5. LAMEA Digital Health For Cardiovascular Market by Component
Chapter 6. LAMEA Digital Health For Cardiovascular Market by End-use
Chapter 7. LAMEA Digital Health For Cardiovascular Market by Country
Chapter 8. Company Profiles
Companies Mentioned
- Apple, Inc.
- Orange S.A.
- Epic Systems Corporation
- Siemens Healthineers AG (Siemens AG)
- GE HealthCare Technologies, Inc.
- CardiAI.Inc
- Vista.ai (HeartVista, Inc.)
- Viz.ai, Inc.
- Cleerly, Inc.
- RSIP Vision Ltd.
Methodology
LOADING...
